Page last updated: 2024-10-28

lidocaine and Botulism

lidocaine has been researched along with Botulism in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Botulism: A disease caused by potent protein NEUROTOXINS produced by CLOSTRIDIUM BOTULINUM which interfere with the presynaptic release of ACETYLCHOLINE at the NEUROMUSCULAR JUNCTION. Clinical features include abdominal pain, vomiting, acute PARALYSIS (including respiratory paralysis), blurred vision, and DIPLOPIA. Botulism may be classified into several subtypes (e.g., food-borne, infant, wound, and others). (From Adams et al., Principles of Neurology, 6th ed, p1208)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carcamo, CR1

Other Studies

1 other study available for lidocaine and Botulism

ArticleYear
Dysarthria Associated with Lumbar Sympathetic Block Using Botulinum Toxin.
    Pain medicine (Malden, Mass.), 2019, 08-01, Volume: 20, Issue:8

    Topics: Adult; Anesthetics, Local; Ankle Fractures; Autonomic Nerve Block; Botulinum Toxins, Type A; Botulis

2019